Etonil 60 mg (Tablet)

Unit Price: ৳ 7.00 (3 x 10: ৳ 210.00)

Strip Price: ৳ 70.00

Medicine Details

Category	Details
Generic	Etoricoxib
Company	Pharmasia limited
Also available as	Etonil 90 mg tablet Etonil 120 mg tablet

Potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor
Decreases clinical signs and symptoms with decreased potential for GI toxicity and effects on platelet aggregation
Primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever

Recommended dose for Osteoarthritis: 30 mg once daily
Recommended dose for Rheumatoid arthritis: 90 mg once daily
Recommended dose for Ankylosing spondylitis: 90 mg once daily
Recommended dose for Acute gouty arthritis: 120 mg once daily for 8 days
Recommended dose for Postoperative dental surgery pain: 90 mg once daily, limited to a maximum of 3 days
Shortest duration and lowest effective daily dose should be used
The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically

Potential interaction with Oral anticoagulants, Diuretics, ACE inhibitors, Angiotensin II Antagonists, Acetylsalicylic Acid, Ciclosporin, Tacrolimus, Lithium
Take without regard to meals

Hypersensitivity to the active substance or to any of the excipients
Active peptic ulceration or active gastrointestinal (GI) bleeding
Patients with bronchospasm, acute rhinitis, nasal polyps, angioneurotic edema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 inhibitors
Pregnancy and lactation
Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10)
Estimated renal creatinine clearance <30 ml/min
Children and adolescents under 16 years of age
Inflammatory bowel disease
Congestive heart failure, Hypertension, Ischaemic heart disease, Peripheral arterial disease, or Cerebrovascular disease

Caution advised with treatment of patients most at risk of developing a GI complication with NSAIDs
Patients with significant risk factors for cardiovascular events should only be treated after careful consideration
Administration of the medicine may cause a reduction in prostaglandin formation and impair renal function
Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension
Patients with symptoms and/or signs suggesting liver dysfunction should be monitored
Discontinue medicine at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity
May mask fever and other signs of inflammation
Caution should be exercised when co-administering with warfarin or other oral anticoagulants

Single doses up to 500 mg and multiple doses up to 150 mg/day did not result in significant toxicity
Usual supportive measures should be employed in the event of overdose